Gisela F. Claassen, Ph.D. - Publications
Affiliations: | 2000 | Vanderbilt University, Nashville, TN |
Area:
Cell Biology, Genetics, Microbiology Biology| Year | Citation | Score | |||
|---|---|---|---|---|---|
| 2004 | Ke N, Claassen G, Yu DH, Albers A, Fan W, Tan P, Grifman M, Hu X, Defife K, Nguy V, Meyhack B, Brachat A, Wong-Staal F, Li QX. Nuclear hormone receptor NR4A2 is involved in cell transformation and apoptosis. Cancer Research. 64: 8208-12. PMID 15548686 DOI: 10.1158/0008-5472.Can-04-2134 | 0.34 | |||
| 2000 | Claassen GF, Hann SR. A role for transcriptional repression of p21CIP1 by c-Myc in overcoming transforming growth factor beta -induced cell-cycle arrest. Proceedings of the National Academy of Sciences of the United States of America. 97: 9498-503. PMID 10920185 DOI: 10.1073/Pnas.150006697 | 0.68 | |||
| 2000 | Niklinski J, Claassen G, Meyers C, Gregory MA, Allegra CJ, Kaye FJ, Hann SR, Zajac-Kaye M. Disruption of Myc-tubulin interaction by hyperphosphorylation of c-Myc during mitosis or by constitutive hyperphosphorylation of mutant c-Myc in Burkitt's lymphoma. Molecular and Cellular Biology. 20: 5276-84. PMID 10866684 DOI: 10.1128/Mcb.20.14.5276-5284.2000 | 0.625 | |||
| 2000 | Chang DW, Claassen GF, Hann SR, Cole MD. The c-Myc transactivation domain is a direct modulator of apoptotic versus proliferative signals. Molecular and Cellular Biology. 20: 4309-19. PMID 10825194 DOI: 10.1128/Mcb.20.12.4309-4319.2000 | 0.677 | |||
| 1999 | Claassen GF, Hann SR. Myc-mediated transformation: the repression connection. Oncogene. 18: 2925-33. PMID 10378689 DOI: 10.1038/Sj.Onc.1202747 | 0.623 | |||
| 1998 | Xiao Q, Claassen G, Shi J, Adachi S, Sedivy J, Hann SR. Transactivation-defective c-MycS retains the ability to regulate proliferation and apoptosis. Genes & Development. 12: 3803-8. PMID 9869633 DOI: 10.1101/Gad.12.24.3803 | 0.696 | |||
| Show low-probability matches. | |||||